Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
SHANGHAI SANYOU MEDICAL CO., LTD. Shanghai Sanyou Medical Co., Ltd. Stock price
Equities
688085
CNE1000040J7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 19.68 CNY | -2.43% | -9.72% | -21.99% | |
| Sales 2023 * | 552M 77.2M | Sales 2024 * | 706M 98.71M | Capitalization | 4.89B 684M |
|---|---|---|---|---|---|
| Net income 2023 * | 121M 16.92M | Net income 2024 * | 157M 21.96M | EV / Sales 2023 * | 8,86x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 6,93x |
| P/E ratio 2023 * | 40,6x | P/E ratio 2024 * | 31,2x | Employees | 434 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 43.96% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.43% | ||
| 1 week | -9.72% | ||
| Current month | -7.65% | ||
| 1 month | -11.35% | ||
| 3 months | -5.88% | ||
| 6 months | -26.84% | ||
| Current year | -21.99% |
1 week
19.65
21.45
1 month
19.6522.76
Current year
19.4832.04
1 year
19.4832.04
3 years
14.1737.99
5 years
14.1774.30
10 years
14.1774.30
| Managers | Title | Age | Since |
|---|---|---|---|
David Fan
FOU | Founder | 54 | 2005 |
Nong Xu
FOU | Founder | 59 | 2005 |
Min Hui Yang
DFI | Director of Finance/CFO | 46 | 2022 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xu Bo Hu
BRD | Director/Board Member | 48 | 2014 |
Nong Xu
FOU | Founder | 59 | 2005 |
David Fan
FOU | Founder | 54 | 2005 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-07 | 19.68 | -2.43% | 1,137,214 |
| 23-12-06 | 20.17 | +0.25% | 1,205,295 |
| 23-12-05 | 20.12 | -0.45% | 1,167,461 |
| 23-12-04 | 20.21 | -3.21% | 2,523,573 |
| 23-12-01 | 20.88 | -2.02% | 3,485,398 |
End-of-day quote Shanghai Stock Exchange, December 06, 2023
More quotes
Shanghai Sanyou Medical Co Ltd is a China-based company mainly engaged in medical equipment business. The Company's main business is the research, development, manufacturing and sales of medical orthopedic implant consumables. Its main products include spinal implant consumable products and trauma implant consumable products. In addition, the Company also develops and produces supporting surgical tools. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-04-22
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
19.68
Average target price
-
Spread / Average Target
-100.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.99% | 700 M $ | |
| +0.33% | 8 565 M $ | |
| -14.84% | 6 366 M $ | |
| +6.84% | 6 047 M $ | |
| -28.03% | 5 475 M $ | |
| +30.73% | 5 258 M $ | |
| +3.61% | 4 585 M $ | |
| -0.39% | 3 517 M $ | |
| +22.67% | 3 474 M $ | |
| -28.47% | 2 352 M $ |
